T. Galeano

Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients.

P. Tassone, P. Tagliaferri, C. Botta, 2017, Blood advances.

Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case‐Control Study

Mario Cannataro, Giuseppe Agapito, Mariamena Arbitrio, 2019, Clinical pharmacology and therapeutics.

mTOR inhibitors, a new era for metastatic luminal HER2-negative breast cancer? A systematic review and a meta-analysis of randomized trials

P. Tassone, P. Tagliaferri, M. Rotundo, 2016, Oncotarget.